Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
Article
Overview
Research
Identity
Additional Document Info
View All
Overview
sustainable development goals
SDG 03: Good Health and Well-being
authors
Vinik, Aaron I.
publication date
2012
webpage
Web of Science
published in
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Journal
Research
keywords
Cycloset
bromocriptine
circadian rhythm
diabetes mellitus type 2
infarction
Identity
PubMed Central ID
PMC3541616
Additional Document Info
volume
1
issue
5